A new assessment tool for people starting cancer treatment
Part of Cancer clinical trials.
This study is testing a new questionnaire and assessment tool to help doctors better understand your overall well-being and needs before you start your first cancer treatment. The goal is to improve care and support for people receiving outpatient cancer treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- You must have a solid tumor (a lump or mass) that has been confirmed by a biopsy.
- You must be able to care for yourself (up and about, not bedridden) — a score of 0 to 2 on a standard scale.
- You must be about to start your first cancer treatment (like chemo, immunotherapy, targeted pills, or a combination) and receive it in an outpatient clinic, not in the hospital.
- You must be able to understand and give written consent, and your doctor expects you to live at least 3 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a practical check-in tool that helps adolescents and young adults track and manage symptoms from cancer or cancer treatment. It may help you better handle symptoms day to day during ongoing treatment.
This study tests a digital tool that uses pictures and simple visuals to help you understand your cancer treatment options. The goal is to make the experience better for you, your family, and your doctors.
This trial tests whether an electronic app and data charts (shown on a tablet) can help patients with cancer better track and share their symptoms and health experiences. You may be able to participate if you are receiving chemotherapy and/or radiation for certain cancers and can use the tablet system.
This study tests a new questionnaire that helps occupational therapists understand the needs of cancer survivors. It is for patients already receiving care at a physical medicine and rehabilitation (PMR) clinic to see how well the tool works.
This study uses advanced testing (molecular profiling and imaging) to better understand cancers and help guide treatment. It is for people with certain advanced cancers who have not yet had immunotherapy or targeted therapy.
This study is testing a new tool designed to help you take a more active role in your healthcare journey. It's for people with early-stage breast cancer that can be surgically removed.
Hear when a new Solid Tumor Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.